Exhibit 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
NUVECTIS PHARMA, INC.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type |
Security Class Title |
Fee Calculation Rule |
Amount Registered (1) |
Proposed Maximum Offering Price Per Share |
Maximum Aggregate Offering Price |
Fee Rate | Amount of Registration Fee |
| Equity | Common Stock, $0.00001 par value |
Other (457(c) and 457(h)) |
559,227 (1) | $5.39 (2) | $3,014,233.53 (2) | $0.00015310 | $461.48 |
| Total Offering Amounts | $3,014,233.53 | ||||||
| Total Fee Offsets(3) | — | ||||||
| Net Fee Due | $461.48 | ||||||
| (1) | Represents shares that may be issued under the Nuvectis Pharma, Inc. Amended and Restated Global Incentive Plan (2021) (the “Plan”), including additional shares that may become issuable in accordance with the adjustment and anti-dilution provisions of the Plan. |
| (2) | Determined pursuant to Rule 457(c) and 457(h) under the Securities Act of 1933, as amended (the “Securities Act”), solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the Company’s common stock (“Common Stock”) on the Nasdaq Capital Market on January 2, 2025. |
| (3) | The Registrant does not have any fee offsets. |